Dakubu S, Hale R, Lu A, Quick J, Solas D, Weinberg J
Baxter Healthcare Corp., Cambridge, MA 02139.
Clin Chem. 1988 Nov;34(11):2337-40.
A time-resolved pulsed fluorescence immunometric assay (TR-PFIA) for carcinoembryonic antigen is described in which either Eu(III) or Tb(III) chelate is used as label. Described in detail is the assay involving the well-documented format of microtiter matrix and Eu(III) fluorescence enhanced with a beta-diketone and quantified in a commercial time-resolving fluorometer. We have also used the same basic assay, but one with a Tb(III) chelate as label, and we read the fluorescence signal directly off a surface without the application of enhancement solution. The Tb(III) fluorescence is then brought into solution by using an analog of dipicolinic acid in an enhancement solution. The latter approach demonstrates the scope of the methodology, which invokes the extra complexity of enhancement only when increased sensitivity might be required. The power and versatility of the enhancement methodology are demonstrated.
本文描述了一种用于癌胚抗原的时间分辨脉冲荧光免疫测定法(TR-PFIA),其中铕(III)或铽(III)螯合物用作标记物。详细描述了该测定法,它采用了微量滴定板基质的成熟形式,并用β-二酮增强铕(III)荧光,并在商用时间分辨荧光计中进行定量。我们还使用了相同的基本测定法,但以铽(III)螯合物作为标记物,并且我们直接从表面读取荧光信号,无需使用增强溶液。然后通过在增强溶液中使用二吡啶甲酸类似物将铽(III)荧光带入溶液中。后一种方法展示了该方法的适用范围,即仅在可能需要提高灵敏度时才引入增强的额外复杂性。展示了增强方法的强大功能和通用性。